Feb 7, 2024
IV Solution & Ketamine Centers of Chicago (844-948-6337) has announced updates to its ketamine treatment programs for sufferers of chronic ailments, including depression, anxiety, PTSD, bipolar disorder, migraine, and fibromyalgia, in West Town.

Chicago, United States - February 7, 2024 /NewsNetwork/ —
With the latest updates to its intravenous ketamine therapies, the center customizes treatment to target the symptoms of treatment-resistant depression (TRD) and other persistent mood disorders and chronic issues.
More information is available at https://chicagoivsolution.com
For patients diagnosed with TRD or another mental health condition, IV Solution & Ketamine Centers of Chicago will administer six infusions of ketamine over a two-week period, followed by maintenance sessions as needed.
Clinical trials have shown that ketamine infusions can result in an 80% success rate in the treatment of TRD. In contrast, oral medications such as SSRIs have only a 60% success rate and are linked to several negative side effects, including impaired cognition, decreased libido, and weight gain, the clinic says.
Ketamine works by blocking the NMDA receptors which are associated with a number of depression symptoms, including anhedonia, increased anxiety, and feelings of overwhelm. Moreover, ketamine is known to stimulate neuronal growth, synaptogenesis, and neuroplasticity, which are essential in resetting the negative thought patterns associated with mood disorders, the team adds.
According to data published by Healthline, a 2022 study found that individuals with TRD who received three IV ketamine infusions in 1 week found it easier to replace negative feelings with more positive ones.
Before undergoing treatment, IV Solution & Ketamine Centers of Chicago will evaluate each patient’s medical history and current condition to determine whether the infusion therapy is right for them. If approved, the patient will return to the practice for 45-minute infusion sessions, during which time they will be closely monitored by trained professionals.
Interested parties can find out more by visiting https://www.facebook.com/ChicagoIVSolution
The treatments can provide relief from the symptoms of major depression and other mood disorders within the first or second infusion. When receiving the subanesthetic dose of ketamine, most patients report feelings of peace and tranquility. For chronic pain conditions, infusions can last up to 4 hours and also require a longer treatment plan.
Given its potential to induce feelings of relaxation and alleviate inflammation, ketamine can also be used to treat chronic pain disorders, IV Solution & Ketamine Centers of Chicago says. While research is still ongoing, it is believed that intravenous ketamine infusions can provide long-lasting relief from mild to moderate pain associated with fibromyalgia and other chronic conditions.
More information can be found by visiting https://twitter.com/Chi_IV_Solution
Contact Info:
Name: Dr. Bal Nandra
Email: Send Email
Organization: IV Solution & Ketamine Centers of Chicago
Address: 712 N Dearborn St , Chicago, IL 60654, United States
Website: https://chicagoivsolution.com/
Source: NewsNetwork
Release ID: 89120654
Should you detect any errors, issues, or discrepancies with the content contained within this press release, or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting [email protected]. Our expert team will be available to promptly respond and take necessary steps within the next 8 hours to resolve any identified issues or guide you through the removal process. We value the trust placed in us by our readers and remain dedicated to providing accurate and reliable information.
Inside China-ASEAN Expo: What new opportunities can AI unlock?
In nearly 30 per cent of companies, productivity fell after teams began using agentic artificial intelligence tools, revealing operational hurdles amid the rapid enterprise adoption of autonomous coding systems, according to McKinsey’s Technology Trends Outlook 2026.
AI adoption rates among major developed economies range from 15–20 per cent, with France, the US, the Netherlands, and the UK at the top end of the range, according to a report by Goldman Sachs Research.
China advances lunar spacesuit, bed rest research for moon landing
US President Donald Trump said Saturday that he is forming an "AI Force" and will announce an "AI Czar" in the near future.
In text exchanges and conversations, multiple people who have worked for leading companies are sceptical of the warnings.
The president said his administration "will not in any way hinder or stifle the growth" amid amid warnings about the emergent technology.
Three researchers at the security firm Hacktron used Anthropic's Claude Opus 5 to chain two flaws and take over the ChatGPT and Codex accounts of several OpenAI employees, then reach an internal OpenAI code repository. The chain began with a bug in the software that runs OpenAI's public help forum and moved through a weakness in OpenAI's own login system. This was security research,
AI-TRUMP:Trump says he will appoint a new AI adviser, without providing details
A bipartisan group in Congress and Gov. Gavin Newsom of California have floated ideas for building a mechanism that would instantly power down an A.I. system. Only no one really knows how.
Apple has introduced its first foldable smartphone, the iPhone Duo, set for release on October 23. VP Tom Marieb detailed the engineering behind its hinge and durability, emphasising the premium feel and extensive effort in design for user safety and reliability.
Google Maps for Android Auto now allows users to customize their driving avatar directly on their car display. This feature, previously limited to smartphones, is part of a server-side update and includes new info cards about destinations, enhancing usability with essential details.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.